|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Net amortization of loans and investment securities | |||||
| Amortization of subordinate debt issuance costs | |||||
| Provision for credit losses | |||||
| Change in fair value of equity securities | |||||
| Realized losses on sales of debt securities | |||||
| Loans originated for sale | |||||
| Proceeds from sale of loans | |||||
| Gain on sale of loans held for sale | |||||
| Increase in fair value of derivative | |||||
| Increase in cash surrender value of life insurance | |||||
| Gains from claims on life insurance policies | |||||
| Stock option compensation | |||||
| Pension plan contribution | |||||
| Increase in other assets | |||||
| (Decrease) increase in other liabilities | |||||
| Deferred tax benefit | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Net decrease in long-term interest-earning deposits in other banks | |||||
| Proceeds from sales and calls of investment securities available for sale | |||||
| Proceeds from maturities and pay-downs of securities available for sale | |||||
| Purchase of investment securities available for sale | |||||
| Net increase in restricted stock | |||||
| Net increase in loans | |||||
| Proceeds from surrender of life insurance policies | |||||
| Proceeds from sale of equity securities | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Net increase in demand deposits, interest-bearing checking, and savings accounts | |||||
| Net (decrease) increase in time deposits | |||||
| Net increase in short-term borrowings | |||||
| Increase in long-term borrowings (FHLB) | |||||
| (Decrease) in long-term borrowings (FHLB & FRB) | |||||
| Redemption of subordinate notes | |||||
| Dividends paid | |||||
| Purchase of Treasury shares | |||||
| Cash received from option exercises | |||||
| Treasury shares issued under dividend reinvestment plan | |||||
| Net cash provided by financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents as of January 1 | |||||
| Cash and cash equivalents as of December 31 | |||||
| Supplemental Disclosures of Cash Flow Information | |||||
| Cash paid during the year for: | |||||
| Interest on deposits and other borrowed funds | |||||
| Income taxes | |||||
| Noncash Activities: | |||||
| Loans transferred to held for sale | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Noncash extinguishment of lease liability | |||||
| Noncash decrease in right-of-use asset | |||||
Loading...
